Document ID: chunk:federal_register_of_legislation:F2024L00743:reg:9:p3
Version: federal_register_of_legislation:F2024L00743
Segment Type: reg
Provision Reference: reg 9 (pt 3/8)
Character Range: 10617–13816

sinus syndrome;
(t)            stenosis of the mitral or aortic valve;
(u)          thrombus within the left atrium or left ventricle; or
(v)          valvulitis of the mitral or aortic valve;
(25)      having one of the following non-cardiac causes of cerebral arterial embolism at the time of the clinical onset:
(a)          aortic arch atherosclerosis;
(b)          decompression sickness;
(c)          endoscopic retrograde cholangiopancreatography;
(d)          pulmonary barotrauma;
(e)          severe bone trauma;
(f)           thrombus formation within the pulmonary vein, or arteries supplying the affected area of the brain;
(26)      having a deep vein thrombosis or venous air embolism with one of the following anatomical defects at the time of clinical onset:
(a)          atrial septal defect;
(b)          patent foramen ovale;
(c)          pulmonary arteriovenous fistula; or
(d)          ventricular septal defect.
Note: Examples of circumstances where venous air embolism may occur include air bubble echocardiogram, sclerotherapy for varicose veins or removal of a central venous catheter.
(27)      undergoing one of the following procedures within the 4 weeks before clinical onset:
(a)          cardiac surgery or cardiac catheterisation;
(b)          catheterisation of or injection into the arteries supplying the brain;
(c)          major surgical procedure involving general or regional anaesthesia, including orthopaedic surgery or neurosurgery; or
(d)          surgery involving the arteries supplying the brain, including carotid endarterectomy;
(28)      having septicaemia or an infection requiring admission to hospital within the 3 months before clinical onset;
(29)      having an injury or illness requiring admission to an intensive care unit or artificial ventilation, within the 3 months before clinical onset;
(30)      having a malignant neoplasm, excluding non-melanotic malignant neoplasm of the skin, within the 1 year before clinical onset;
(31)      having cirrhosis of the liver or chronic liver disease at the time of  clinical onset;
(32)      having chronic kidney disease before clinical onset;
Note: chronic kidney disease is defined in the Schedule 1 – Dictionary.
(33)      experiencing a moderate to severe traumatic brain injury within the 1 year before clinical onset;
(34)      being obese for at least 5 years within the 15 years before clinical onset;
Note: being obese is defined in the Schedule 1 – Dictionary.
(35)      for males, having a waist to hip circumference ratio exceeding 1.0 for at least 5 years within the 15 years before clinical onset;
(36)      for females, having a waist to hip circumference ratio exceeding 0.9 for at least 5 years within the 15 years before clinical onset;
(37)      for intracerebral haemorrhage only, being underweight for at least 5 years within the 10 years before clinical onset;
Note: being underweight is defined in the Schedule 1 - Dictionary.
(38)      having symptomatic inflammatory bowel disease within the ten years before clinical onset;
(39)      having clinically significant depressive disorder within the 2 years  before clinical onset;
Note: clinically significant is defined in